Loudness dependence of auditory evoked potentials (LDAEP) in clinical monitoring of suicidal patients with major depression: A pilot study

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 6, 2012, Pages 487-492

  Uhl, Idun ^a   Illes, Franciska ^a   Graßnickel, Vanessa ^a   Echterhoff, Silke ^b   Norra, Christine ^a   Juckel, Georg ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b LWL Hospital Herten   (Germany)

Author keywords

Auditory evoked potentials; Depression; Intensity dependence; LDAEP; Serotonin; Suicidality

Indexed keywords

AMFEBUTAMONE; CHLORPROTHIXENE; DULOXETINE; ESCITALOPRAM; FLUNITRAZEPAM; FLUOXETINE; LORAZEPAM; MIRTAZAPINE; OLANZAPINE; PIPAMPERONE; PROMETHAZINE; QUETIAPINE; TEMAZEPAM; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; EVOKED AUDITORY RESPONSE; FEMALE; FOLLOW UP; GENDER; HAMILTON SCALE; HUMAN; IMPULSIVENESS; LETHALITY; LOUDNESS DEPENDENCE OF AUDITORY EVOKED POTENTIAL; MAJOR DEPRESSION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOPHARMACOTHERAPY; SEROTONINERGIC SYSTEM; SMOKING; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

ADULT; DEPRESSIVE DISORDER, MAJOR; EVOKED POTENTIALS, AUDITORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; PILOT PROJECTS; SEROTONERGIC NEURONS; STATISTICS, NONPARAMETRIC; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; TIME FACTORS;

EID: 84867018362     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-012-0297-8     Document Type: Article

References (55)

1. Agren H, Niklasson F (1986) Suicidal potential in depression: focus on CSF monoamine and purine metabolites. Psychopharmacol Bull 22:656-660 (Pubitemid 17183361)
2. Agren H, Osterberg B, Franzen O (1983) Depression and somatosensory evoked potentials: II. Correlations between SEP and depressive phenomenology. Biol Psychiatry 18:651-659 (Pubitemid 13067599)
3. Asberg M, Träskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33:1193-1197
4. Asberg M, Nordström P, Träskman-Bendz L (1986) Cerebrospinal fluid studies in suicide. An overview. Ann N Y Acad Sci 487:243-255
5. Banki CM, Molnar G, Vojnik M (1981) Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms. J Affect Disord 3:91-99 (Pubitemid 11112281)
6. Becker U, Laakmann G, Baghai T, Kuhn K, Kauert G (1996) Liquor-5HT und depressive Störungen. Nervenarzt 67:65
7. Buchsbaum MS, Haier RJ, Murphy DL (1977) Suicide attempts, platelet monoamine oxidase and the average evoked response. Acta Psychiatr Scand 56:69-79 (Pubitemid 8130339)
8. Chen TJ, Yu YW, Chen MC, Wang SY, Tsai SJ, Lee TW (2005) Serotonin dysfunction and suicide attempts in major depressives: an auditory event-related potential study. Neuropsychobiology 52:28-36 (Pubitemid 40910947)
9. Cooper S, Kelly CB (1992) Psychopharmacology of depression and anxiety. Curr Op Psychiatry 5:79-83
10. Coryell W, Schlesser M (2001) The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158:748-753 (Pubitemid 32429843)
11. Coryell W, Schlesser M (2007) Combined biological tests for suicide prediction. Psychiatry Res 150:187-191 (Pubitemid 46386297)
12. Cremniter D, Thenault M, Jamain S, Meidinger A, Delmas C, Gaillard M (1994) Serotonine and suicide: a preliminary study concerning a sample of violent suicidal patients. Prog Neuropsychopharmacol Biol Psychiatry 18:871-878 (Pubitemid 24234870)
13. Gallinat J, Kunz D, Lang UE, Kalus P, Juckel G, Eggers J, Mahlberg R, Staedtgen M, Wernicke C, Rommelspacher H, Smolka MN (2005) Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing. Pharmacopsychiatry 38:158-160 (Pubitemid 41059221)
14. Gardner DL, Lucas PB, Cowdry RW (1990) CSF metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry 28:247-254 (Pubitemid 20226412)
15. Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33:173-187 (Pubitemid 23089966)
16. http://www.euro.who.int/en/what-we-do/health-topics/diseases- andconditions/mental-health/facts-and-figures
17. Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, Möller HJ, Müller N, Hegerl U (2003) Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64:115-124 (Pubitemid 37412333)
18. Juckel G, Hegerl U (1994) Evoked potentials, serotonin, and suicidality. Pharmacopsychiatry 27(Suppl 1):27-29 (Pubitemid 24260111)
19. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G (1999) Auditory evoked potentials reflect serotonergic neuronal activity- a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21:710-716
20. Juckel G, Mavrogiorgou P, Bredemeier S, Gallinat J, Frodl T, Schulz C, Möller HJ, Hegerl U (2004) Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders-a retrospective study. Pharmacopsychiatry 37:46-51 (Pubitemid 38651016)
21. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G (1997) Auditory-evoked potentials as indicator of brain serotonergic activity-first evidence in behaving cats. Biol Psychiatry 41:1181-1195 (Pubitemid 27237179)
22. Keilp JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, Mann JJ (2010) Future suicide attempt and responses to serotonergic challenge. Neuropsychopharmacology 35:1063-1072
23. Lemus CZ, Lieberman JA, Johns CA, Pollack S, Bookstein P, Cooper TB (1990) CSF 5-hydroxyindoleacetic acid levels and suicide attempts in schizophrenia. Biol Psychiatry 27:926-929 (Pubitemid 20145681)
24. Lester D (1995) The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a metaanalysis. Pharmacopsychiatry 28:45-50
25. Lidberg L, Tuck JR, Asberg M, Scalia-Tomba GP, Bertilsson L (1985) Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand 71:230-236 (Pubitemid 15169898)
26. Lindström MB, Ryding E, Bosson P, Ahnlide JA, Rosén I, Träskman-Bendz L (2004) Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. Eur Neuropsychopharmacol 14:295-300 (Pubitemid 38649086)
27. Malone KM, Waternaux C, Haas GL, Cooper TB, Li S, Mann JJ (2003) Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry 160: 773-779 (Pubitemid 41079612)
28. Mann JJ, Arango V (1992) Integration of neurobiology and psychopathology in a unified model of suicidal behavior. J Clin Psychopharmacol 12(2 Suppl):2S-7S
29. Mann JJ, Malone KM, Psych MR, Sweeney JA, Brown RP, Linnoila M, Stanley B, Stanley M (1996) Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 15:576-586 (Pubitemid 26400762)
30. Mann JJ, Brent DA, Arango V (2001) The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24:467-477 (Pubitemid 32244308)
31. Möller HJ, Baldwin DS, Goodwin G, Kasper S, Okasha A, Stein DJ, Tandon R, Versiani M, WPA Section on Pharmacopsychiatry (2008) Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci 258(Suppl 3):3-23
32. Müller-Oerlinghausen B, Roggenbach J (2002) Concretism in biological suicide research-are we eating the menu instead of the meal? Some thoughts on present research strategies. Pharmacopsychiatry 35:44-49 (Pubitemid 34293232)
33. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ (2006) Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21:47-52 (Pubitemid 43192475)
34. Ninan PT, van Kammen DP, Scheinin M, Linnoila M, Bunney WE Jr, Goodwin FK (1984) CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am J Psychiatry 141: 566-569 (Pubitemid 14163269)
35. Nock MK, Hwang I, Sampson N, Kessler RC, Angermeyer M, Beautrais A, Borges G, Bromet E, Bruffaerts R, de Girolamo G, de Graaf R, Florescu S, Gureje O, Haro JM, Hu C, Huang Y, Karam EG, Kawakami N, Kovess V, Levinson D, Posada-Villa J, Sagar R, Tomov T, Viana MC, Williams DR (2009) Crossnational analysis of the associations among mental disorders and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS Med 6:e1000123
36. Nordström P, Asberg M (1992) Suicide risk and serotonin. Int Clin Psychopharmacol 6(Suppl. 6):12-21
37. Nordström P, Samuelsson M, Asberg M, Träskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L (1994) CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 24:1-9 (Pubitemid 24116677)
38. Norra C, Mrazek M, Tuchtenhagen F, Gobbelé R, Buchner H, Sass H, Herpertz SC (2003) Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J Psychiatr Res 37:23-33 (Pubitemid 35449768)
39. Norra C, Becker S, Bröcheler A, Kawohl W, Kunert HJ, Buchner H (2008) Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 23:31-42 (Pubitemid 351166066)
40. Oliva J, Leung S, Croft RJ, O'Neill BV, O'Kane J, Stout J, Phan KL, Nathan PJ (2010) The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission. Hum Psychopharmacol 25:423-427
41. O'Neill BV, Guille V, Croft RJ, Leung S, Scholes KE, Phan KL, Nathan PJ (2008) Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol 23: 301-312 (Pubitemid 351982667)
42. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ (2003) Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 60:14-22 (Pubitemid 36070860)
43. Peabody CA, Faull KF, King RJ, Whiteford HA, Barchas JD, Berger PA (1987) CSF amine metabolites and depression. Psychiatry Res 21:1-7 (Pubitemid 17119163)
44. Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G, Folkerts M, Chouker M, Riedel M, Zaudig M, Moller HJ, Hegerl U (2004) Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 29:1910-1917 (Pubitemid 39336802)
45. Pompili M, Serafini G, Innamorati M, Möller-Leimkühler AM, Giupponi G, Girardi P, Tatarelli R, Lester D (2010) The hypothalamic- pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. Eur Arch Psychiatry Clin Neurosci 260(8):583-600
46. Roggenbach J, Müller-Oerlinghausen B, Franke L (2002) Suicidality, impulsivity and aggression-is there a link to 5-HIAA concentration in the cerebrospinal fluid? Psychiatry Res 113:193-206 (Pubitemid 35447736)
47. Roy A, De JJ, Linnoila M (1989) Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry 46:609-612 (Pubitemid 19180339)
48. Roy A, Ninan P, Mazonson A, Pickar D, Van KD, Linnoila M, Paul SM (1985) CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Psychol Med 15:335-340 (Pubitemid 15117707)
49. Ryding E, Ahnlide JA, Lindström M, Rosén I, Räskman-Bendz L (2006) Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 148:195-203 (Pubitemid 44750588)
50. Simmons JG, Nathan PJ, Berger G, Allen NB (2011) Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants. Psychopharmacology (Berl) 217:101-110
51. Spreux-Varoquaux O, Alvarez JC, Berlin I, Batista G, Despierre PG, Gilton A, Cremniter D (2001) Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression. Life Sci 69:647-657 (Pubitemid 32673623)
52. Träskman L, Asberg M, Bertilsson L, Sjostrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631-636 (Pubitemid 11064819)
53. Träskman-Bendz L, Asberg M, Schalling D (1986) Serotonergic function and suicidal behavior in personality disorders. Ann N Y Acad Sci 487:168-174
54. Uhl I, Gorynia I, Gallinat J, Mulert C, Wutzler A, Heinz A, Juckel G (2006) Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21:463-471 (Pubitemid 44660186)
55. van Praag HM, Plutchik R, Conte H (1986) The serotonin hypothesis of (auto)aggression. Critical appraisal of the evidence. Ann N Y Acad Sci 487:150-167